ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1823

Unsupervised Cluster Analysis of Clinical and Ultrasound Features Reveals Unique Gout Subtypes: Results from the Egyptian College of Rheumatology (ECR)

Tamer A Gheita1, Ahmed M Elsaman2, Aly Bakhiet3, Mohamed Bakrey Mahmoud4, Faten Ismail5, Hanan El Saadany6, Rawhya R ElShereef5, Eman F Mohamed7, Mervat I Abd Elazeem8, Ayman Eid8, Fatma Ali5, Mona Hamdy5, Reem El Mallah9, Reem HA Mohammed1, Samar Tharwat10, Rania M Gamal11, Samar Fawzy1, Soha Senara12, Hanan M Fathi12, Adham Aboul Fotouh13 and Nevin Hammam14, 1Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt, 2Rheumatology Department, Faculty of Medicine, Sohag University, Sohag, Egypt, 3Higher Institute for Computer Science and Information Systems, 6th of October City, Assiut, Egypt, 4Higher Institute for Computer Science and Information Systems, 6th of October City, Cairo, Egypt, 5Rheumatology Department, Faculty of Medicine, Minia University, Minia, Egypt, 6Rheumatology Department, Tanta University, Gharbia, Egypt, 7Internal Medicine Department, Rheumatology Unit, Faculty of Medicine (Girls), Al-Azhar University, Cairo, Egypt, 8Rheumatology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt, 9Rheumatology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt, 10Internal Medicine, Rheumatology Unit, Mansoura University, Dakahlia, Egypt, Dakahlia, Egypt, 11Rheumatology Department, Faculty of Medicine, Al-Azhar University, Assiut, Egypt, 12Rheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt, 13Egyptian School for Musculoskeletal Ultrasonography (EgySMUS); Egyptian Society of Musculoskeletal and Neuromuscular Sonography (ESMNS), Cairo, Egypt, 14Rheumatology Department, Faculty of Medicine, Assiut University, Assiut, Egypt, PASADENA, CA

Meeting: ACR Convergence 2022

Keywords: gout, Ultrasound

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Gout comprises a heterogeneous group of disorders characterized by inflammatory arthritis associated with comorbidities leading to impaired quality of life, and an extensive burden on health care costs. Musculoskeletal ultrasound (MSUS) has shown great advantages in the diagnosis of gout; with its incorporation in the latest American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) gout classification criteria. Efforts to subtype the disease have been limited to the impact of comorbidities on gout patients, and no attempt has been made to describe how ultrasonographic features combined with clinical and laboratory characteristics categorize the population with gout into subtypes. Here, we applied unsupervised clustering analysis to identify clinically-relevant phenotypes in patients with gout on the basis of MSUS findings and to investigate differences across clusters.

Methods: This was a cross-sectional multicentre study of 425 gouty patients who met the ACR/EULAR classification criteria in the Egyptian College of Rheumatology (ECR)-MSUS Study Group, a nationally representative sample. Variables including demographic, lifestyle factors, clinical manifestations, comorbidities, and laboratory findings were selected for analysis. Musculoskeletal scans evaluated bilateral knee and 1st MTP joints for joint effusion, synovial proliferation, joint erosions, urate crystal deposits (double contour, aggregates), and power Doppler (PD) signal as a marker of local inflammation. We conducted a K-mean cluster analysis; the characteristics of each cluster were compared using the Chi-square test for categorical variables and one-way ANOVA for numeric outcomes.

Results: Overall, 425 patients, 267 (62.8%) male; mean (SD) age, 54.2 (10.3) years; and 364 (85.6%) had mono/oligoarticular involvement were included in the analysis. Three distinct clusters were identified in our dataset (Table 1). Cluster 1 (n=138, 32.5%) has the lowest overall disease burden with a lower frequency of MSUS features than other clusters, representing the benign disease subtype. Cluster 2 (n=140, 32.9%) was predominantly women and had the smallest number of smokers with a relatively low rate of patients receiving urate-lowering therapy (ULT) and an intermediate frequency of comorbidities. Cluster 3 (n=147, 34.6%), the most severe disease burden, with the highest proportion of patients with comorbidities, and were receiving ULT (Table 1). Significant MSUS differences between cluster 2 and 3 were observed for joint effusion (p< 0.0001; highest: Cluster 3); power Doppler signal (p< 0.0001; highest: Clusters 2); aggregates of crystals deposition (p< 0.0001; highest: Cluster 3); and presence of double contour (p=0.014; highest: Cluster 3) (Figure 1).

Conclusion: Cluster combined clinical and ultrasound findings from adults with gout identified three differentiated subgroups. Ultrasound may help in identifying different disease phenotypes and could support more tailoring of treatments at various stages of gout. Thus, we should pay attention to the musculoskeletal ultrasound findings when treating patients with gout.

Acknowledgment: We would like to thank Rasha Fawzy, and Doaa Mosaad.

Supporting image 1

SD: standard deviation; WBCs, PLT, ESR, SUA
*Cluster 2 vs cluster 1, ** Cluster 3 vs cluster 1, *** Cluster 2 vs cluster 3.
Definition: Obesity was defined as body mass index ≥30 kg/m2. Hypertension was defined as blood pressure≥130/90 mm Hg or current antihypertensive treatment. Diabetes was defined as a fasting glycemia>1.26 g/L or the use of antidiabetic drugs. Renal disorders were defined as glomerular filtration rate <60 mL/min, proteinuria, and abnormal urinary sediment. The liver disorder was defined by the presence of hepatic steatosis or cirrhosis or abnormal liver enzyme levels. Dyslipidemia was defined by the presence of hypertriglyceridemia or hypercholesterolemia.

Supporting image 2


Disclosures: T. Gheita, None; A. M Elsaman, None; A. Bakhiet, None; M. Bakrey Mahmoud, None; F. Ismail, None; H. El Saadany, None; R. R ElShereef, None; E. F Mohamed, None; M. I Abd Elazeem, None; A. Eid, None; F. Ali, None; M. Hamdy, None; R. El Mallah, None; R. HA Mohammed, None; S. Tharwat, None; R. M Gamal, None; S. Fawzy, None; S. Senara, None; H. M Fathi, None; A. Aboul Fotouh, None; N. Hammam, None.

To cite this abstract in AMA style:

Gheita T, M Elsaman A, Bakhiet A, Bakrey Mahmoud M, Ismail F, El Saadany H, R ElShereef R, F Mohamed E, I Abd Elazeem M, Eid A, Ali F, Hamdy M, El Mallah R, HA Mohammed R, Tharwat S, M Gamal R, Fawzy S, Senara S, M Fathi H, Aboul Fotouh A, Hammam N. Unsupervised Cluster Analysis of Clinical and Ultrasound Features Reveals Unique Gout Subtypes: Results from the Egyptian College of Rheumatology (ECR) [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/unsupervised-cluster-analysis-of-clinical-and-ultrasound-features-reveals-unique-gout-subtypes-results-from-the-egyptian-college-of-rheumatology-ecr/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unsupervised-cluster-analysis-of-clinical-and-ultrasound-features-reveals-unique-gout-subtypes-results-from-the-egyptian-college-of-rheumatology-ecr/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology